Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€18.87

€18.87

3.160%
0.575
3.160%
-

-

 
27.03.24 / Tradegate WKN: A2PGL8 / Symbol: PTIE / Name: Cassava Sciences / Stock / Micro Cap /

Cassava Sciences Inc. Stock

A very strong showing by Cassava Sciences Inc. today, with an increase of €0.58 (3.160%) compared to yesterday's price.
For the coming years our community has positive and negative things to say abot the Cassava Sciences Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Expected Cash Flow" there were negative voices in the community.

Pros and Cons of Cassava Sciences Inc. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-12-09

Cassava Sciences Inc, trading under the symbol PTIE, exhibits financials that immediately catch the eye due to the absence of revenue generation across the reported periods, which naturally dictates a unique analytical approach. In scrutinizing the financial statements and ancillary ratios, the general assessment suggests a company heavily invested in research and development. The lack of revenue suggests PTIE is likely in a developmental phase, typical of biotech companies focusing on drug development and awaiting regulatory approval and commercialization of their products.

General Impressions:

Exploring the various financial statements and ratios reveals a firm with substantial assets, primarily cash, and minimal revenue. This liquidity indicates a company that has raised capital, possibly channeling these funds towards advancement in their research. However, with significant R&D expenses leading to sustained net losses over time, the financials reflect a company that is burning through cash at a fast pace.

Comments

Buy Cassava Sciences Inc.
Show more

Sell Cassava Sciences Inc.
Show more